RESUMO
PURPOSE: The aim of this analysis is to compare the pharmacokinetics of drug substrates in healthy Chinese and European subjects of aligned CYP2C9, CYP2C19, or CYP2D6 enzyme activity, providing further insight into drivers of interethnic differences in pharmacokinetics. METHODS: Following identification of appropriate drug substrates, a comprehensive and structured literature search was conducted to identify single-dose pharmacokinetic data in healthy Chinese or European subjects with reported CYP2C9, CYP2C19, or CYP2D6 activity (genotype or phenotype). The ratio of drug AUC in the Chinese and European subjects classified with aligned enzyme activity was calculated (ethnicity ratio (ER)). RESULTS: For 22/25 drugs identified, the ERs calculated indicated no or only limited interethnic differences in exposure (Assuntos
Citocromo P-450 CYP2C19/metabolismo
, Citocromo P-450 CYP2C9/metabolismo
, Citocromo P-450 CYP2D6/metabolismo
, Farmacocinética
, Polimorfismo Genético
, Algoritmos
, Área Sob a Curva
, Povo Asiático
, China
, Estudos de Coortes
, Citocromo P-450 CYP2C19/genética
, Citocromo P-450 CYP2C9/genética
, Citocromo P-450 CYP2D6/genética
, Bases de Dados Genéticas
, Bases de Dados de Produtos Farmacêuticos
, Feminino
, Humanos
, Internet
, Masculino
, Preparações Farmacêuticas/sangue
, Farmacogenética/métodos
, Especificidade por Substrato
, População Branca